CompletedNCT05496413
Investigating the Cognitive Source of Visual Working Memory Impairment in Schizophrenia
This study has finished and is no longer accepting participants.
In New Taipei CitySchizophreniaDevice studyAges 20–65
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Active Not RecruitingNCT06278246
Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography
Official study title
The Muscarinic Hypothesis of Schizophrenia: an [11C]MK-6884 PET Study Study Protocol
This study is no longer accepting new participants.
In TorontoSchizophreniaObservational studyAges 18+
CompletedNCT04350775
Investigation of Community Reablement on Instrumental Activities of Daily Living in People With Schizophrenia
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaPlacebo comparisonAges 20–99
CompletedNCT05137158
iTBS on Negative Symptoms and Cognitive Function in Schizophrenia
Official study title
The Effect of Intermittent Theta Burst Stimulation on Negative Symptoms And Cognitive Function in Schizophrenia
This study has finished and is no longer accepting participants.
In ChangshaSchizophreniaDevice studyAges 18–60
CompletedNCT05110157
Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia
Official study title
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixSchizophreniaMedication studyAges 18+
CompletedNCT00145444
Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Study
Official study title
A Multicenter, Double-Blind, Randomized Trial Of Ziprasidone (80 - 160 Mg) Versus Olanzapine (10 - 20 Mg) In Patients With Recent-Onset Schizophrenia, Schizoaffective And Schizophreniform Disorder.
This study has finished and is no longer accepting participants.
Multiple locations, including AntwerpSchizophreniaMedication studyAges 18–40
TerminatedNCT05968638
Ketogenic Diet in People With Schizophrenia
Official study title
Single-Blind Randomized Ketogenic Diet vs. Control Diet in People With Schizophrenia
This study ended early.
In CatonsvilleSchizophreniaPlacebo comparisonAges 18–64
CompletedNCT06502509
Kombucha Tea for Improving Defecation in people with Schizophrenia- a Controlled Study
Official study title
How Does Kombucha Tea Improve Difficulty During Defecation in Patients With Schizophrenia- A Randomized, Double-blinded, Placebo-controlled, Parallel Study
This study has finished and is no longer accepting participants.
In CaotunSchizophreniaPlacebo comparisonAges 20–65
WithdrawnNCT04054973
L-arginine Study for Persistent Symptoms of Schizophrenia
Official study title
An Open-label Feasibility Trial of Adjunctive L-arginine and Tetrahydrobiopterin Combination in Patients With Treatment Resistant Schizophrenia
This study was withdrawn before enrollment.
In WorcesterSchizophreniaMedication studyAges 18–65
TerminatedNCT03432000
Links Between Perception of Temporal Order Judgment and Causality in Schizophrenia
Official study title
Study of the Links Between Perception of Temporal Order Judgment and Causality in Schizophrenic Spectrum Disorders
This study ended early.
In BronSchizophreniaInterventional studyAges 18–45
CompletedNCT01074073
Lithium Drug-Drug Interaction Study With Lurasidone HCl
Official study title
A Phase 1, Open-Label, 2-Period, Sequential, Drug-Drug Interaction Study To Determine The Effect Of Lithium 600 Mg BID On The Safety And Pharmacokinetics Of Lurasidone 120 Mg QD In Patients With Schizophrenia Or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In Culver CitySchizophreniaMedication studyAges 18–65
WithdrawnNCT01584466
Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Study
Official study title
Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study
This study was withdrawn before enrollment.
In CatonsvilleSchizophreniaMedication studyAges 18–64
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.